LifeSignals Receives HSA Clearance For Tripatch ECG Remote Monitoring Biosensor Platform In Singapore


LifeSignals receives HSA clearance for Tripatch™ ECG Remote Monitoring Biosensor Platform (LX1250) in Singapore

FREMONT, Calif.- LifeSignals Inc., today announced clearance for the Tripatch* ECG Remote Monitoring Biosensor Platform in Singapore from the Health Sciences Authority (HSA), a statutory body under the Ministry of Health of the Singapore Government. Tripatch is a wireless remote monitoring system intended for use by healthcare professionals for continuous collection of Electrocardiography (ECG) and Heart Rate monitoring in ambulatory, hospital, and healthcare settings. Patient data can be transmitted throughout the care continuum wirelessly with ultra-high reliability from the Tripatch Biosensor to cloud-based platforms for storage and analysis. Healthcare professionals can then remotely access this data and rapidly make treatment decisions independent of patient location.

According to Ministry of Health figures, almost one out of three deaths in Singapore is caused by heart diseases or stroke 1. Welcoming the HSA clearance, Surendar Magar, co-founder, and CEO of LifeSignals said: “We believe Tripatch can make a major contribution to cardiovascular care in Singapore. For the first time, a patient’s clinical data can be captured seamlessly from any setting – hospital, ambulatory, or home – and securely transmitted wirelessly to existing medical monitoring systems in current hospitals or new cloud-based systems for analysis. By “untethering” the patient, healthcare professionals can make faster treatment decisions, while patients can be confident of receiving data-driven, personalized therapy.”

The Tripatch wireless medical biosensor has been developed with a number of enhanced features:

2-channel ECG to ensure optimal data integrity
3-day data capture and heart rate analysis for enhanced diagnosis single-Use, ‘Fit &Forget’ disposable device for improved patient compliance and reduced risk of cross-infection
Adaptable to many clinical workflows, including Remote Patient Monitoring system, Mobile Cardiac Telemetry System, Holter, and Event Monitoring.
LifeSignals have created a fully interoperable technology that can easily be integrated into most health monitoring platforms, apps, and healthcare systems. We are actively seeking companies and organizations to partner with, so together, we can bring clinical-grade remote monitoring to a much wider patient base, helping reduce the burden on healthcare systems.

About LifeSignals, Inc.
LifeSignals (formerly HMicro Inc.) is the Silicon Valley-based creator and producer of the patented LifeSignals Processor, a semiconductor platform designed to faithfully capture and communicate vital life signals from humans and animals to the cloud. LifeSignals is a venture capital-backed, a fabless semiconductor company, enabled by equity investments from Flex, Uniquest, Dreamtech, Renew Group, Seraph Capital, Xseed Capital, and Reddy Capital. Further information can be found at


Kim Ramessa
Marketing and Communications Director
LifeSignals Group
M: +44 (0) 7425 316305


Richard Hayhurst
M: +44 (0) 7711 821527